A century ago, August Krogh's interest in diabetes led to the creation of insulin. Novo Nordisk developed GLP-1 analogues that evolved into successful diabetes treatments. The emergence of once-weekly formulations like Ozempic has shown remarkable weight-loss results, sparking hope and excitement among patients and healthcare providers. These medications have the potential to address the obesity epidemic by offering effective solutions for weight management.
A otro idioma
del contenido fuente
www.newyorker.com
Ideas clave extraídas de
by Cond... a las www.newyorker.com 12-14-2023
https://www.newyorker.com/culture/2023-in-review/the-year-of-ozempicConsultas más profundas